Article
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.
Journal of virology - 1 Sept 2009
van der Sanden Sabine, Pallansch Mark A, van de Kassteele Jan, El-Sayed Nasr, Sutter Roland W, Koopmans Marion, van der Avoort Harrie
Abstract excerpt
For the final stages in the eradication of poliovirus type 1 (P1), the World Health Organization advocates the selective use of monovalent type 1 oral poliovirus vaccine (mOPV1). To compare the immunogenicity of mOPV1 with that of trivalent OPV (tOPV) in infants, a study was performed in Egypt in 2005. Newborns were vaccinated with mOPV1 or tOPV immediately after birth and were challenged with mOPV1 after 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
